New Zealand - Re-Export of Vaccines for Human Use
Since 2014, New Zealand Re-Export of Vaccines for Human Use increased 27.2% year on year. At $346,218.92 in 2019, the country was ranked number 8 comparing other countries in Re-Export of Vaccines for Human Use. New Zealand is overtaken by Georgia, which was ranked number 7 with $363,839.78 and is followed by Fiji with $323,463.43. United States lead the ranking with $21,386,560.62 in 2019, a decrease of 18% versus 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana witnessed the best average annual growth at +106.5% per year, while Trinidad and Tobago witnessed the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 346,218.91 |
| 2018 | 105,745.03 |
| 2017 | 1,091,326.25 |
| 2016 | 197,567.63 |
| 2015 | 60,868.23 |
Download all data from 1989 to 2019
How does New Zealand rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 7 |
#7
Georgia
|
363,839.78 | 2019 | +234.4 % | -23.6 % | View data | |
| 8 |
#8
New Zealand
|
346,218.91 | 2019 | +227.4 % | +27.2 % | View data | |
| 9 |
#9
Fiji
|
323,463.43 | 2019 | +10.9 % | -2.9 % | View data | |